Signed by District Judge Denise Page Hood. Steury v. Cardinal Health, Inc.,625 F.3d 262, 266 (5th Cir. Find more than 21 complaints| Ripoff Report. 623 Highland Colony Parkway, Suite 100. [21-30534] (Imad Sayed Matini ) [Entered: 09/13/2021 04:00 PM], APPEARANCE FORM for the court's review. 2008). Id. And by breaching the Agreement, AIS caused BCBS to wrongfully pay the S9328 code. P. 57. We have designed private, spacious, comfortable, and relaxing suites which include: Heated massage chairs. 3:11 . BCBS and AHS seek declaratory judgment, asking the Court to declare that BCBS has no contractual obligation to pay the alleged unpaid, mispresented claims. Ridgeland, MS 39157. miles away. AIS and AHS entered into a Preferred Home Care Provider Participating Agreement ("Agreement) in 2008 and 2015 to provide infusion therapy services to BCBS subscribers. [21-30534] (SEP) [Entered: 10/21/2021 11:21 AM], SUFFICIENT - UNOPPOSED MOTION to supplement the record on appeal with Reasons in Support of Order granting Motion to Dismiss [9692325-2]. Id. ADVANCED INFUSION SOLUTIONS; NPI #1336243393 - NPIdb.org AHS is a subsidiary of BCBS that maintains and operates BCBS provider networks in Mississippi. ADVANCED INFUSION SOLUTIONS. Escamilla v. Blue Cross Blue Shield of Michigan, d/b/a BCBSM, Wilber v. Compcare Health Services Insurance Corp et al, Mills v. Blue Cross Blue Shield Association et al, Nichols v. Blue Cross Blue Shield of Michigan, Michigan Catastrophic Claims Association v. Steadfast Insurance Company, Bradley v. Blue Cross Blue Shield of Michigan, Display Pack, Inc. v. LEL International, Inc. et al, Romano v. Blue Cross Blue Shield of Michigan. Contacts. Filed: August 27, 2021. BCBS and AHS (collectively "Counter-Plaintiffs") answered and asserted a counterclaim against AIS, stating claims of breach of contract, misrepresentation, breach of the duty of good faith and fair dealing, and unjust enrichment, as well as seeking declaratory relief that BCBS has no contractual obligation to pay the unpaid claims. Advanced Pain . ADVANCED HEALTH SYSTEMS, INC. and BLUE CROSS & BLUE SHIELD OF MISSISSIPPI, A MUTUAL INSURANCE COMPANY, Defendants. 27-29, 37, and establishes the remaining elements with particularity, see id. [Previously dismissed case: No] [Possible companion case(s): None] (Moody, Nolan) (Entered: 01/11/2021), U.S. Courts Of Appeals | Contract | A subscription to PACER is required. Lead Counsel? texts to send an aries man Search. R. Civ. ORDER KRISTI H. JOHNSON, District Judge. The covenant of good faith and fair dealing is implied in every contract. Date of service: 10/19/2021. Spokeo, 578 U.S. at 340-41). AIS is a specialty pharmacy that provides home infusion therapy, which infuses patients' pain medications into the intrathecal space surrounding their spinal cord through surgically implanted pumps. Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017. The medication in the pump lasts between a week and several months without requiring the patient to see a healthcare provider. Provider Organization. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia. [21-30534] (Charles H. Spencer-Davis ) [Entered: 09/13/2021 04:12 PM], APPEARANCE FORM FILED by Attorney(s) Imad Sayed Matini for party(s) Appellee Bond Pharmacy, Incorporated, in case 21-30534. Maness v. K & A Enters. Fed. Doesn't sound . Advanced Infusion Solutions (AIS) Fabricacin de productos farmacuticos Ridgeland, Mississippi MMM Holdings LLC . Redaction Request due 7/27/2021. 2010). BOND PHARMACY d/b/a, ADVANCED INFUSION SOLUTIONS Plaintiff, The site is secure. Release of Transcript Restriction set for 10/4/2021. Phone/Fax numbers are the same for each location: Phone: 360-933-4892 Toll Free: 888-960-1873 Fax: 360-933-1197. Motion Hearing set for 6/23/2021 04:00 PM before District Judge Denise Page Hood |Zoom Webinar Information: https://www.zoomgov.com/j/1616326086?pwd=dTVZRnlseVBTNFRhNVE0SlhQaEozUT09 Passcode: 999999 Or One tap mobile : US: +16692545252,,1616326086# or +16468287666,,1616326086#| (LSau) (Entered: 05/11/2021), (#22) NOTICE of Appearance by Kevin M. Cloutier on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. (Court Reporter/Transcriber: Sheri Ward, www.transcriptorders.com) (Number of Pages: 21) The parties have 21 days to file with the court and Court Reporter/Transcriber a Redaction Request of this transcript. Subscribe to Justia's Free Newsletters featuring summaries of federal and state court opinions. 03/16/2022. Id. Plaintiff requests summons issued. Infusion Solutions, LLC, was founded in 2020 by Annette Bennett and Lucien Roberts. 2012) (internal quotations omitted)). In other words, unjust enrichment only applies when: "[(1)] there is no legal contract and [(2)] the person sought to be charged is in possession of money or property which in good conscience and justice he should not retain but should deliver to another." 2:19-CV-12369 | 2019-08-09, U.S. District Courts | Other | Find 2014 - 2015 Compounding: Inspections, Recalls, and other Actions in the FDA Archive, | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |, | Contract Testing Labs | Active Ingredient Suppliers |, Abbott's Compounding Pharmacy Inc., Berkeley, CA - 503A Facility, ABC Pharmacy, Inc., Encino, CA- 503A Facility, Abilene Nuclear LLC, (dba National Central Pharmacy), Abilene, TX - 503A Facility - Ceased Compounding Operations, Abrams Royal Pharmacy, Dallas, TX- 503A Facility, Abrams Royal Pharmacy II, LLC, Plano, TX- 503A Facility, Absolute Pharmacy, LLC, Lutz, FL- 503A Facility - De-registered as an Outsourcing Facility, Absolute Veterinary Compounding Pharmacy, Weatherford, TX- 503A Facility, AcariaHealth Pharmacy, Inc., Falls Chuch, VA- 503A Facility - Ceased Compounding Operations, Accurate Rx Pharmacy Consulting, LLC (dba Accurate Rx Pharmacy), Columbia, MO- 503A Facility, A Chem Rx, LLC, (dba Cortez Drugs), Brooksville, FL- 503A Facility, ACRX Specialty Pharmacy Inc., Las Vegas, NV- 503A Facility, Advanced Care Infusion-Shelby, (see Tri-Med, Inc.), Shelby Township, MI- 503A Facility, Advanced Compounding Solutions, (see New England Life Care, Inc.), Woburn, MA- 503A Facility, Advanced Infusion Solutions, Clinton, MS- 503A Facility, Advanced Infusion Solutions, (see Bond Pharmacy, Inc.), Ridgeland, MS- 503A Facility, Advanced Nutriceuticals, LLC, Indianapolis, IN- 503A Facility, Advanced Physician Solutions, Inc., N Hollywood, CA- 503A Facility - Out of business, Advanced Specialty Pharmacy(dba Meds IV), Bessemer, AL- 503A Facility, Aerosol Science Laboratories Inc., Camarillo, CA- 503A Facility, Age Management, Santa Barbara, CA- 503A Facility, Akina Pharmacy, Chantilly, VA- 503A Facility, Akorn Pharmaceuticals Inc. Decatur, IL- 503A Facility, Alexander Infusion, LLC (dba Avanti Health Care Services), New Hyde Park, NY- 503A Facility - De-registered as an Outsourcing Facility, Alexandria Medical Arts Pharmacy & Compounding Laboratory,(see J & F International Inc.), Alexandria, VA- 503A Facility, Alfred I. duPont Hospital for Children, Wilmington, DE- 503A Facility, Algunas, Inc. (dba Woodland Hills Compounding Pharmacy), Woodland Hills, CA- 503A Facility, Allegheny Health Network Home Infusion, LLC, Sharpsburg, PA- 503A Facility, Alwan's Pharmacy (see American Pharmacy of Illinois, Inc.), Peoria, IL- 503A Facility, Ambient Healthcare of Central Florida Inc., Ocala, FL- 503A Facility, American Family Pharmacy, LLC, Indianapolis, IN- 503A Facility, American Hormones Inc. Poughkeepsie, NY- 503A Facility, American Hormones, Inc., Wappingers Falls, NY- 503A Facility, American Pharmacy of Illinois, Inc. (dba Alwan's Pharmacy), Peoria, IL- 503A Facility, American Specialty Pharmacy, Dallas, TX- 503A Facility - Out of business, American Specialty Pharmacy, Plano, TX- 503A Facility - Ceased Compounding Operations, American Specialty Pharmacy, Inc., (dba ASP Cares), San Antonio, TX- 503A Facility - De-registered as an Outsourcing Facility, Americare Compounding, LLC, Garden City South, NY- 503A Facility, Ameridose, LLC, Westborough, MA- 503A Facility, Amex Pharmacy, (see Pacifico National Inc.), Melbourne, FL- 503A Facility, Anazaohealth Corporation, Tampa, FL- 503A Facility, Anazaohealth Corporation, Las Vegas, NV- 503B Facility, Anchor Drugs Pharmacy, (see Jajco, Inc.), South San Francisco, CA- 503A Facility, Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy, Bristol, TN- 503A Facility, Anderson Holdings Inc. (dba Wingate's Pharmacy and Compounding),Nashua, NH- 503A Facility, Apex Pharmacy, LLC, Beckley, WV- 503A Facility, Apollo Care LLC, Columbia, MO- 503B Facility, ApothCure, Inc., Dallas, TX- 503A Facility, APS Pharmacy, (see Drug Depot, Inc.), Palm Harbor, FL- 503A Facility, ARJ Infusion Services, Inc., Lenexa, KS- 503A Facility, Ark Pharmacy, PC (dba Regency Medical Pharmacy), Newbury Park, CA- 503A Facility, Arnold Professional Pharmacy, Arnold, MD- 503A Facility, ASP Cares, (seeAmerican Specialty Pharmacy, Inc.), San Antonio, TX- 503A Facility - De-registered as an Outsourcing Facility, Aspirar Pharmacy, LLC, Cary, NC- 503A Facility, Assurance Infusion, (see Nanobots Healthcare, LLC), Houston, TX- 503A Facility, Asteria Health, (see FH Investments Inc.), Birmingham, AL- 503A Facility, Athena Pharmacy (see Paradigm Healthcare Solutions, LLC), Mount Juliet, TN- 503A Facility, Athenex Pharma Solutions, LLC, Clarence, NY- 503B Facility, Atlas Pharmaceuticals, LLC, Phoenix, AZ- 503B Facility, Auro Pharmacies, Inc., La Habra, CA- 503A Facility - Out of business, Avanti Health Care Services, (see Alexander Infusion, LLC), New Hyde Park, NY- 503A Facility, Avella of Deer Valley, Inc. (dba Avella Specialty Pharmacy),Phoenix, AZ- 503A Facility - De-registered as an Outsourcing Facility, Avella Specialty Pharmacy, (formerly Advanced Pharma, Inc.), Houston, TX- 503A Facility - Out of business, Avenue Pharmacy, Inc., (dba Pathway Pharmacy), Ocala, FL- 503A Facility, Axia Pharmaceuticals, (see Fusion IV Pharmaceuticals Inc.), Los Angeles, CA- 503A Facility, Axis Pharmacy Northwest, (see Shiraz Specialty Pharmacy Inc.), Mountlake Terrace, WA- 503A Facility, Axium Healthcare Pharmacy (dba Balanced Solutions Compounding), Lake Mary, FL- 503A Facility - Out of business, B & B Pharmacy, (see BBS Pharmacy, Inc.), Bellflower, CA- 503A Facility, Balanced Solutions Compounding,(see Axium Healthcare Pharmacy), Lake Mary, FL- 503A Facility - Out of business, Ballard Plaza Pharmacy 1 Inc., Seattle, WA- 503A Facility - Out of business, Banner Pharmacy Services, LLC, Chandler, AZ- 503A Facility - De-registered as an Outsourcing Facility, Baptist Health Medical Towers Pharmacy and Infusion Services, Little Rock, AR- 503A Facility, Barclay Luke & Pillai Specialty Pharmacy PLLC (dba Meta Pharmacy Services), Las Vegas, NV- 503A Facility, Baycare Integrated Service Center, LLC dba BayCare Central Pharmacy, Temple Terrace, FL- 503B Facility, Bayview Pharmacy, Inc., Saunderstown, RI- 503A Facility, BBS Pharmacy, Inc. (dba B&B Pharmacy), formerly Pacific Healthcare, Inc., Bellflower, CA- 503A Facility, Beacon Hill Medical Pharmacy, P.C.
Homes For Sale In Paris France Zillow, 2019 California Green Building Standards Code Dwg, Circle K Easy Pay Card Activation, Live Cameras In Pigeon Forge, Navitus Health Solutions Appeal Form, Articles A